{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:10:27Z","timestamp":1789603827641,"version":"build-2803163510"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/md.0000000000008801","type":"journal-article","created":{"date-parts":[[2017,11,14]],"date-time":"2017-11-14T18:18:27Z","timestamp":1510683507000},"page":"e8801","source":"Crossref","is-referenced-by-count":22,"title":["Evaluation of anti-desmoglein-1 and anti-desmoglein-3 autoantibody titers in pemphigus patients at the time of the initial diagnosis and after clinical remission"],"prefix":"10.1097","volume":"96","author":[{"given":"Irene","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Paolo","family":"De Siena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Saponeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Alaibac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-106-20210226","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1600-0625.2005.00367.x","article-title":"Mechanisms of blister induction by autoantibodies","volume":"14","author":"Sitaru","year":"2005","journal-title":"Exp Dermatol"},{"key":"R2-106-20210226","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.clindermatol.2011.01.013","article-title":"Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis)","volume":"29","author":"Joly","year":"2011","journal-title":"Clin Dermatol"},{"key":"R3-106-20210226","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(05)66829-8","article-title":"Pemphigus","volume":"366","author":"Bystryn","year":"2005","journal-title":"Lancet"},{"key":"R4-106-20210226","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.autrev.2010.08.007","article-title":"Modern diagnosis of autoimmune blistering skin diseases","volume":"10","author":"Schmidt","year":"2010","journal-title":"Autoimmun Rev"},{"key":"R5-106-20210226","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jaad.2004.02.013","article-title":"Management of autoimmune bullous diseases: pharmacology and therapeutics","volume":"51","author":"Mutasim","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R6-106-20210226","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2133.2003.05665.x","article-title":"Guidelines for the management of pemphigus vulgaris","volume":"149","author":"Harman","year":"2003","journal-title":"Br J Dermatol"},{"key":"R7-106-20210226","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1517\/21678707.2013.775933","article-title":"Contemporary management of pemphigus","volume":"1","author":"Hammers","year":"2013","journal-title":"Expert Opin Orphan Drugs"},{"key":"R8-106-20210226","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-4632.2006.02593.x","article-title":"Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris","volume":"45","author":"Sharma","year":"2006","journal-title":"Int J Dermatol"},{"key":"R9-106-20210226","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1468-3083.2011.04294.x","article-title":"Utility of desmoglein ELISA in the clinical correlation and disease monitoring of pemphigus vulgaris","volume":"26","author":"Anand","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R10-106-20210226","first-page":"529","article-title":"ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus","volume":"45","author":"Abasq","year":"2009","journal-title":"Arch Dermatol"},{"key":"R11-106-20210226","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/1523-1747.ep12606168","article-title":"Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus","volume":"104","author":"Amagai","year":"1995","journal-title":"J Invest Dermatol"},{"key":"R12-106-20210226","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","article-title":"Characterization of autoantibodies in pemphigus using antigen-specific ELISAs with baculovirus-expressed recombinant desmogleins","volume":"159","author":"Ishii","year":"1997","journal-title":"J Immunol"},{"key":"R13-106-20210226","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0190-9622(99)70183-0","article-title":"The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile","volume":"40","author":"Amagai","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"R14-106-20210226","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2133.2002.04838.x","article-title":"Monitoring disease activity in pemphigus with enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3","volume":"147","author":"Cheng","year":"2002","journal-title":"Br J Dermatol"},{"key":"R15-106-20210226","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/0378-6323.25780","article-title":"Study of desmoglein 1 and 3 antibody levels in relation to disease severity in Indian patients with pemphigus","volume":"72","author":"Kumar","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R16-106-20210226","first-page":"12","article-title":"Immunopathologic features of pemphigus in the east Mediterranean region of Turkey: a prospective study","volume":"8","author":"Akman","year":"2010","journal-title":"Skinmed"},{"key":"R17-106-20210226","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol"},{"key":"R18-106-20210226","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1468-3083.2008.02715.x","article-title":"Anti-desmoglein IgG autoantibodies in patients with pemphigus in remission","volume":"22","author":"Kwon","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R19-106-20210226","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2133.2000.03660.x","article-title":"A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype","volume":"143","author":"Harman","year":"2000","journal-title":"Br J Dermatol"},{"key":"R20-106-20210226","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1468-3083.2011.04428.x","article-title":"Correlation of antibodies against desmogleins 1 and 3 with indirect immunofluorescence and disease status in a Greek population with pemphigus vulgaris","volume":"27","author":"Avgerinou","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R21-106-20210226","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1600-0625.2010.01069.x","article-title":"Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients","volume":"19","author":"Schmidt","year":"2010","journal-title":"Exp Dermatol"},{"key":"R22-106-20210226","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1468-3083.2007.02254.x","article-title":"Desmoglein 1 and 3 enzyme- linked immunosorbent assay in Iranian patients with pemphigus vulgaris: correlation with phenotype, severity, and disease activity","volume":"21","author":"Daneshpazhooh","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R23-106-20210226","doi-asserted-by":"crossref","first-page":"187864","DOI":"10.1155\/2009\/187864","article-title":"Detection of autoantibodies against recombinant desmoglein 1 and 3 molecules in patients with pemphigus vulgaris: correlation with disease extent at the time of diagnosis and during follow-up","volume":"2009","author":"Belloni-Fortina","year":"2009","journal-title":"Clin Dev Immunol"},{"key":"R24-106-20210226","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/ced.12187","article-title":"Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris","volume":"39","author":"Daneshpazhooh","year":"2013","journal-title":"Clin Exp Dermatol"},{"key":"R25-106-20210226","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2133.2012.10929.x","article-title":"Detection of antibodies against the non-calcium-dependent epitopes of desmoglein 3 in pemphigus vulgaris and their pathogenic significance","volume":"167","author":"Kamiya","year":"2012","journal-title":"Br J Dermatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T13:54:06Z","timestamp":1693230846000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201711170-00106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":25,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008801","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}